Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.06)
# 1,178
Out of 5,172 analysts
71
Total ratings
29.58%
Success rate
6.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Reiterates: Buy | $25 | $3.49 | +616.33% | 3 | Mar 17, 2026 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $25 | $3.85 | +550.20% | 3 | Mar 17, 2026 | |
| ALT Altimmune | Maintains: Buy | $12 → $25 | $3.34 | +648.50% | 3 | Mar 16, 2026 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.17 | +1,115.56% | 2 | Mar 13, 2026 | |
| ALGS Aligos Therapeutics | Reiterates: Buy | $50 | $6.81 | +634.21% | 3 | Mar 11, 2026 | |
| QURE uniQure | Reiterates: Buy | $70 | $16.09 | +335.05% | 7 | Mar 10, 2026 | |
| GOSS Gossamer Bio | Maintains: Buy | $10 → $5 | $0.42 | +1,083.71% | 2 | Mar 6, 2026 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $115 → $145 | $71.62 | +102.46% | 4 | Mar 4, 2026 | |
| VIR Vir Biotechnology | Maintains: Buy | $15 → $20 | $9.10 | +119.78% | 3 | Mar 4, 2026 | |
| PHVS Pharvaris | Reiterates: Buy | $60 | $25.98 | +130.95% | 4 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $1.85 | +2,332.43% | 5 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $95 | $4.62 | +1,956.28% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $70 | $18.40 | +280.43% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $70 | $13.97 | +401.07% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $70 | $5.41 | +1,193.90% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $27.72 | +98.41% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $510 | $312.17 | +63.37% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $56.33 | +77.53% | 5 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.33 | +2,914.77% | 2 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $29.91 | +234.34% | 2 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $28.46 | +75.69% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.34 | +646.27% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.95 | +952.63% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.38 | +624.64% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $21.47 | +132.88% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $24.63 | +224.81% | 2 | Oct 10, 2025 |
AtaiBeckley
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.49
Upside: +616.33%
Voyager Therapeutics
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.85
Upside: +550.20%
Altimmune
Mar 16, 2026
Maintains: Buy
Price Target: $12 → $25
Current: $3.34
Upside: +648.50%
Silence Therapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $75
Current: $6.17
Upside: +1,115.56%
Aligos Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $50
Current: $6.81
Upside: +634.21%
uniQure
Mar 10, 2026
Reiterates: Buy
Price Target: $70
Current: $16.09
Upside: +335.05%
Gossamer Bio
Mar 6, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $0.42
Upside: +1,083.71%
Bright Minds Biosciences
Mar 4, 2026
Maintains: Buy
Price Target: $115 → $145
Current: $71.62
Upside: +102.46%
Vir Biotechnology
Mar 4, 2026
Maintains: Buy
Price Target: $15 → $20
Current: $9.10
Upside: +119.78%
Pharvaris
Mar 3, 2026
Reiterates: Buy
Price Target: $60
Current: $25.98
Upside: +130.95%
Mar 3, 2026
Maintains: Buy
Price Target: $40 → $45
Current: $1.85
Upside: +2,332.43%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $95
Current: $4.62
Upside: +1,956.28%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $70
Current: $18.40
Upside: +280.43%
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $70
Current: $13.97
Upside: +401.07%
Mar 2, 2026
Maintains: Buy
Price Target: $40 → $70
Current: $5.41
Upside: +1,193.90%
Feb 25, 2026
Reiterates: Buy
Price Target: $55
Current: $27.72
Upside: +98.41%
Feb 18, 2026
Reiterates: Buy
Price Target: $510
Current: $312.17
Upside: +63.37%
Feb 10, 2026
Reiterates: Buy
Price Target: $100
Current: $56.33
Upside: +77.53%
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.33
Upside: +2,914.77%
Feb 4, 2026
Reiterates: Buy
Price Target: $100
Current: $29.91
Upside: +234.34%
Dec 22, 2025
Reiterates: Buy
Price Target: $50
Current: $28.46
Upside: +75.69%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.34
Upside: +646.27%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.95
Upside: +952.63%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.38
Upside: +624.64%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $21.47
Upside: +132.88%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $24.63
Upside: +224.81%